- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Industry News: Visage takes a down-under look
The new owner of Visage Imaging, Pro Medicus, is showing a jewel in its new crown.
The new owner of Visage Imaging, Pro Medicus, is showing a jewel in its new crown. The Australian company is previewing a newly forged link between its radiology information system and recently acquired PACS and Visage CS, a thin-client advanced visualization system. ProMedicus acquired the advanced imaging technologies through its $3 million cash purchase Jan. 28 of Visage Imaging from Mercury Computer.
Visage Imaging did not fit comfortably under Mercury’s umbrella of mostly defense-related projects. Pro Medicus and Visage Imaging appear to be better suited. Since 1983, Pro Medicus has provided integrated software products and services to healthcare providers for more than 25 years. The advanced visualization on which Mercury founded Visage now gives the Australian firm an edge over competitors, according to Sam Hupert, cofounder and executive director of Pro Medicus.
“I know that any company can go all the way from scheduling through PACS and to 3D visualization,” Hupert said.
Visage has a strong foothold in the PACS and 3D visualization marketplace, claiming 1200 clients who use its health-related visualization products marketed either directly under the Visage brand or by OEMs. Its new owner views the adoption of digital technology as a key growth area. The acquisition allows Pro Medicus to expand its product portfolio with a RIS, complementary PACS, and advanced visualization that will open a new front in the market addressing 3D and 4D postprocessing of CT and MR, a critical capability in the future evolution of radiology.
“We believe there will be a huge future for 3D,” he said. “More and more radiologists will read volumes rather than 2D.”
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.
Can Autonomous AI Help Reduce Prostate MRI Workloads Without Affecting Quality?
March 1st 2024Based on findings from a multicenter study of over 1,600 patients, researchers at the European Congress of Radiology suggest the inclusion of autonomous artificial intelligence (AI) triage could facilitate up to a 75 percent reduction in prostate MRI reading workload.
Five Insights on Artifacts and Limitations with Contrast-Enhanced Mammography
February 29th 2024Noting that technique issues, patient positioning miscues and atypical features can all contribute to faulty interpretation with contrast-enhanced mammography (CEM), researchers at the European Congress of Radiology shared their insights on navigating artifacts and limitations with CEM.
ECR Study Examines Key Predictive Factors for Metastasis in Patients with High-Risk Prostate Cancer
February 28th 2024Sixty-five percent of patients with newly diagnosed high-risk prostate cancer may have extraprostatic extension on MRI, and PSMA PET/CT findings suggest those with Gleason scores of eight or higher have more than double the risk of metastasis, according to a new study presented at the European Congress of Radiology (ECR).
